The hypocretins and their role in narcolepsy

CNS and Neurological Disorders - Drug Targets

Volumn 8, Issue 4, 2009, Pages 271-280

  Kroeger, Daniel ^a   De Lecea, Luis ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Arousal; Feeding behavior; Hypocretin; Narcolepsy; Neuroanatomy; Optogenetics

Indexed keywords

OREXIN; G PROTEIN COUPLED RECEPTOR; NEUROPEPTIDE; NEUROPEPTIDE RECEPTOR; OREXIN RECEPTORS; OREXINS; SIGNAL PEPTIDE;

APPETITE; AROUSAL; ENERGY METABOLISM; FEEDING BEHAVIOR; HUMAN; NARCOLEPSY; NERVE PROJECTION; NEUROANATOMY; NEUROENDOCRINOLOGY; NEUROMODULATION; NEUROPATHOLOGY; NEUROPHARMACOLOGY; NEUROPHYSIOLOGY; NONHUMAN; REINFORCEMENT; REVIEW; ANIMAL; BIOLOGICAL MODEL; BRAIN; DOG; DRUG EFFECT; GENETICS; HISTOLOGY; HYPOTHALAMUS; METABOLISM; MOUSE; MOUSE MUTANT; NERVE TRACT; PATHOPHYSIOLOGY; PHYSIOLOGY; REWARD; SENSORY NERVE;

AFFERENT PATHWAYS; ANIMALS; APPETITE; AROUSAL; BRAIN; DOGS; FEEDING BEHAVIOR; HUMANS; HYPOTHALAMUS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, KNOCKOUT; MODELS, NEUROLOGICAL; NARCOLEPSY; NEURAL PATHWAYS; NEUROPEPTIDES; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NEUROPEPTIDE; REWARD;

EID: 70350435276     PISSN: 18715273     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152709788921645     Document Type: Review

References (134)

1. Gautvik, K.M.; de Lecea, L.; Gautvik, V.T.; Danielson, P.E.; Tranque, P.; Dopazo, A.; Bloom, F.E.; Sutcliffe, J.G. Overview of the most prevalent hypothalamus-specific mRNAs, as identified by directional tag PCR subtraction. Proc. Natl. Acad. Sci. USA, 1996, 93, 8733-8738.
2. Usui, H.; Falk, J.; Dopazo, A.; de Lecea, L.; Erlander, M.; Sutcliffe, J.G. Isolation of clones of rat striatum-specific mRNAs by directional tag PCR subtraction. J. Neurosci., 1994, 14, 4915-4926.
3. de Lecea, L.; Kilduff, T.S.; Peyron, C.; Gao, X.-B.; Foye, P.E.; Danielson, P.E.; Fukuhara, C.; Battenberg, E.L.; Gautvik, V.T.; Bartlett, F.S., 2nd.; Frankel, W.N.; van den Pol, A.N.; Bloom, F.E.; Gautvik, K.M.; Sutcliffe, J.G. The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl. Acad. Sci. USA, 1998, 95, 322-327.
4. Sakurai, T.; Amemiya, A.; Ishii, M.; Matsuzaki, I.; Chemelli, R.M.; Tanaka, H.; Williams, S.C.; Richardson, J.A.; Kozlowski, G.P.; Wilson, S.; Arch, J.R.; Buckingham, R.E.; Haynes, A.C.; Carr, S.A.; Annan, R.S.; McNulty, D.E.; Liu, W.S.; Terrett, J.A.; Elshourbagy, N.A.; Bergsma, D.J.; Yanagisawa, M. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell, 1998, 92, 573-585.
5. Willie, J.T.; Chemelli, R.M.; Sinton, C.M.; Yanagisawa, M. To eat or sleep? Orexin in the regulation of feeding and wakefulness. Annu. Rev. Neurosci., 2001, 24, 429-458.
6. Peyron, C.; Tighe, D.K.; van den Pol, A.N.; de Lecea, L.; Heller, H.C.; Sutcliffe, J.G.; Kilduff, T.S. Neurons Containing Hypocretin (Orexin) Project to Multiple Neuronal Systems. J. Neurosci., 1998,, 18, 9996-10015.
7. Modirrousta, M.; Mainville, L.; Jones, B.E. Orexin and MCH neurons express c-Fos differently after sleep deprivation vs recovery and bear different adrenergic receptors. Eur. J. Neurosci., 2005, 21, 2807-2816.
8. Harrison, T.A.; Chen, C.T.; Dun, N.J.; Chang, J.K. Hypothalamic orexin A-immunoreactive neurons project to the rat dorsal medulla. Neurosci. Lett., 1999, 273, 17-20.
9. Thannickal, T.C.; Moore, R.Y.; Nienhuis, R.; Ramanathan, L.; Gulyani, S.; Aldrich, M.; Cornford, M.; Siegel, J.M. Reduced number of hypocretin neurons in human narcolepsy. Neuron, 2000, 27, 469-474.
10. Date, Y.; Ueta, Y.; Yamashita, H.; Yamaguchi, H.; Matsukura, S.; Kangawa, K.; Sakurai, T.; Yanagisawa, M.; Nakazato, M. Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc. Natl. Acad. Sci. USA, 1999, 96, 748-753.
11. Caillol, M.; Aïoun, J.; Baly, C.; Persuy, M.-A.; Salesse, R. Localization of orexins and their receptors in the rat olfactory system: possible modulation of olfactory perception by a neuropeptide synthetized centrally or locally. Brain Res., 2003, 960, 48-61.
12. Ciriello, J.; Rosas-Arellano, M.P.; Solano-Flores, L.P.; de Oliveira, C.V.R. Identification of neurons containing orexin-B (hypocretin-2) immunoreactivity in limbic structures. Brain Res., 2003, 967, 123-131.
13. Gerashchenko, D.; Shiromani, P. Different neuronal phenotypes in the lateral hypothalamus and their role in sleep and wakefulness. Mol. Neurobiol., 2004, 29, 41-59.
14. Oh-I, S.; Shimizu, H.; Satoh, T.; Okada, S.; Adachi, S.; Inoue, K.; Eguchi, H.; Yamamoto, M.; Imaki, T.; Hashimoto, K.; Tsuchiya, T.; Monden, T.; Horiguchi, K.; Yamada, M.; Mori, M. Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature, 2006, 443, 709-712.
15. Nambu, T.; Sakurai, T.; Mizukami, K.; Hosoya, Y.; Yanagisawa, M.; Goto, K. Distribution of orexin neurons in the adult rat brain. Brain Res., 1999, 827, 243-260.
16. Chen, C.T.; Dun, S.L.; Kwok, E.H.; Dun, N.J.; Chang, J.K. Orexin A-like immunoreactivity in the rat brain. Neurosci. Lett., 1999, 260, 161-164.
17. Horvath, T.L.; Diano, S.; van den Pol, A.N. Synaptic interaction between hypocretin (orexin) and neuropeptide Y cells in the rodent and primate hypothalamus: a novel circuit implicated in metabolic and endocrine regulations. J. Neurosci., 1999, 19, 1072-1087.
18. Guan, J.-L.; Wang, Q.-P.; Shioda, S. Immunoelectron microscopic examination of orexin-like immunoreactive fibers in the dorsal horn of the rat spinal cord. Brain Res., 2003, 987, 86-92.
19. van den Pol, A.N. Hypothalamic hypocretin (orexin): robust innervation of the spinal cord. J. Neurosci., 1999, 19, 3171-82.
20. Cutler, D.J.; Morris, R.; Sheridhar, V.; Wattam, T.A.K.; Holmes, S.; Patel, S.; Arch, J.R.; Wilson, S.; Buckingham, R.E.; Evans, M.L.; Leslie, R.A.; Williams, G. Differential distribution of orexin-A and orexin-B immunoreactivity in the rat brain and spinal cord [small star, filled]. Peptides, 1999, 20, 1455-1470.
21. Zhu, Y.; Miwa, Y.; Yamanaka, A.; Yada, T.; Shibahara, M.; Abe, Y.; Sakurai, T.; Goto, K. Orexin receptor type-1 couples exclusively to pertussis toxin-insensitive g-proteins, while orexin receptor type-2 couples to both pertussis toxin-sensitive and - insensitive g-proteins. J. Pharmacol. Sci., 2003, 92, 259-266.
22. Hoang, Q.V.; Bajic, D.; Yanagisawa, M.; Nakajima, S.; Nakajima, M. Effects of orexin (hypocretin) on GIRK channels. J. Neurophysiol., 2003, 90, 693-702.
23. Aston-Jones, G.; Zhu, Y.; Card, J.P. Numerous GABAergic afferents to locus ceruleus in the pericerulear dendritic zone: possible interneuronal pool. J. Neurosci., 2004, 24, 2313-2321.
24. Seininger, T.L.K.; T.S. In Hypocretins: Integrators of physiological signals. De Lecea, L.S.J.G., Ed.; Springer: New York, 2005, p. 14.
25. Nixon, J.; Smale, L. A comparative analysis of the distribution of immunoreactive orexin A and B in the brains of nocturnal and diurnal rodents. Behav. Brain Funct., 2007, 3, 28.
26. Aston-Jones, G.; Smith, R.J.; Moorman, D.E.; Richardson, K.A. Role of lateral hypothalamic orexin neurons in reward processing and addiction. Neuropharmacology, 2009, 56, 112-121.
27. Harris, G.C.; Wimmer, M.; Aston-Jones, G. A role for lateral hypothalamic orexin neurons in reward seeking. Nature, 2005, 437, 556-559.
28. Yoshida, K.; McCormack, S.; España, R.A.; Crocker, A.; Scammell, T.E. Afferents to the orexin neurons of the rat brain. J. Comp. Neurol., 2006, 494, 845-861.
29. Abrahamson, E.E.; Leak, R.K.; Moore, R.Y. The suprachiasmatic nucleus projects to posterior hypothalamic arousal systems. Neuroreport, 2001, 12, 435-440.
30. Deurveilher, S.; Semba, K. Indirect projections from the suprachiasmatic nucleus to major arousal-promoting cell groups in rat: implications for the circadian control of behavioural state. Neuroscience, 2005, 130, 165-183.
31. Li, Y.; Gao, X.-B.; Sakurai, T.; van den Pol, A.N. Hypocretin/orexin excites hypocretin neurons via a local glutamate neuron a potential mechanism for orchestrating the hypothalamic arousal system. Neuron, 2002, 36, 1169-1181.
32. Yamanaka, A.; Muraki, Y.; Tsujino, N.; Goto, K.; Sakurai, T. Regulation of orexin neurons by the monoaminergic and cholinergic systems. Biochem. Biophys. Res. Commun., 2003, 303, 120-129.
33. Bayer, L.; Eggermann, E.; Serafin, M.; Grivel, J.; Machard, D.; Muhlethaler, M.; Jones, B.E. Opposite effects of noradrenaline and acetylcholine upon hypocretin/orexin versus melanin concentrating hormone neurons in rat hypothalamic slices. Neuroscience, 2005, 130, 807-811.
34. Grivel, J.; Cvetkovic, V.; Bayer, L.; Machard, D.; Tobler, I.; Mühlethaler, M.; Serafin, M. The wake-promoting hypocretin/orexin neurons change their response to noradrenaline after sleep deprivation. J. Neurosci., 2005, 25, 4127-4130.
35. Yamanaka, A.; Beuckmann, C.T.; Willie, J.T.; Hara, J.; Tsujino, N.; Mieda, M.; Tominaga, M.; Yagami, K.; Sugiyama, F.; Goto, K.; Yanagisawa, M.; Sakurai, T. Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron, 2003, 38, 701-713.
36. Acuna-Goycolea, C.; van den Pol, A. Glucagon-like peptide 1 excites hypocretin/orexin neurons by direct and indirect mechanisms: implications for viscera-mediated arousal. J. Neurosci., 2004, 24, 8141-8152.
37. Winsky-Sommerer, R.; Yamanaka, A.; Diano, S.; Borok, E.; Roberts, A.J.; Sakurai, T.; Kilduff, T.S.; Horvath, T.L.; de Lecea, L. Interaction between the corticotropin-releasing factor system and hypocretins (orexins): a novel circuit mediating stress response. J. Neurosci., 2004, 24, 11439-11448.
38. Wollmann, G.; Acuna-Goycolea, C.; van den Pol, A.N. Direct excitation of hypocretin/orexin cells by extracellular atp at p2x receptors. J. Neurophysiol., 2005, 94, 2195-2206.
39. Tsujino, N.; Yamanaka, A.; Ichiki, K.; Muraki, Y.; Kilduff, T.S.; Yagami, K.; Takahashi, S.; Goto, K.; Sakurai, T. Cholecystokinin activates orexin/hypocretin neurons through the cholecystokinin A receptor. J. Neurosci., 2005, 25, 7459-7469.
40. Xie, X.; Crowder, T.L.; Yamanaka, A.; Morairty, S.R.; LeWinter, R.D.; Sakurai, T.; Kilduff, T.S. GABA(B) receptor-mediated modulation of hypocretin/orexin neurones in mouse hypothalamus. J. Physiol., 2006, 574, 399-414.
41. Burdakov, D.; Gerasimenko, O.; Verkhratsky, A. Physiological changes in glucose differentially modulate the excitability of hypothalamic melanin-concentrating hormone and orexin neurons in situ. J. Neurosci., 2005, 25, 2429-2433.
42. Burdakov, D.; Jensen, L.T.; Alexopoulos, H.; Williams, R.H.; Fearon, I.M.; O'Kelly, I.; Gerasimenko, O.; Fugger, L.; Verkhratsky, A. Tandem-pore k+ channels mediate inhibition of orexin neurons by glucose. Neuron, 2006, 50, 711-722.
43. Muraki, Y.; Yamanaka, A.; Tsujino, N.; Kilduff, T.S.; Goto, K.; Sakurai, T. Serotonergic regulation of the orexin/hypocretin neurons through the 5-ht1a receptor. J. Neurosci., 2004, 24, 7159-7166.
44. Fu, L.-Y.; Acuna-Goycolea, C.; van den Pol, A.N. Neuropeptide Y inhibits hypocretin/orexin neurons by multiple presynaptic and postsynaptic mechanisms: tonic depression of the hypothalamic arousal system. J. Neurosci., 2004, 24, 8741-8751.
45. Liu, Z.-W.; Gao, X.-B. Adenosine inhibits activity of hypocretin/orexin neurons by the a1 receptor in the lateral hypothalamus: a possible sleep-promoting effect. J. Neurophysiol., 2007, 97, 837-848.
46. Chemelli, R.M.; Willie, J.T.; Sinton, C.M.; Elmquist, J.K.; Scammell, T.; Lee, C.; Richardson, J.A.; Williams, S.C.; Xiong, Y.; Kisanuki, Y.; Fitch, T.E.; Nakazato, M.; Hammer, R.E.; Saper, C.B.; Yanagisawa, M. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell, 1999, 98, 437-451.
47. Bingham, S.; Davey, P.T.; Babbs, A.J.; Irving, E.A.; Sammons, M.J.; Wyles, M.; Jeffrey, P.; Cutler, L.; Riba, I.; Johns, A.; Porter, R.A.; Upton, N.; Hunter, A.J.; Parsons, A.A. Orexin-A, an hypothalamic peptide with analgesic properties. Pain, 2001, 92, 81-90.
48. Ehrstrom, M.; Naslund, E.; Ma, J.; Kirchgessner, A.L.; Hellstrom, P.M. Physiological regulation and NO-dependent inhibition of migrating myoelectric complex in the rat small bowel by OXA. Am. J. Physiol. Gastrointest. Liver Physiol., 2003, 285, G688-G695.
49. Naslund, E.; Ehrstrom, M.; Ma, J.; Hellstrom, P.M.; Kirchgessner, A.L. Localization and effects of orexin on fasting motility in the rat duodenum. Am. J. Physiol. Gastrointest. Liver Physiol., 2002, 282, G470-G479.
50. Cluderay, J.E.; Harrison, D.C.; Hervieu, G.J. Protein distribution of the orexin-2 receptor in the rat central nervous system. Regul. Peptides, 2002, 104, 131-144.
51. Greco, M.A.; Shiromani, P.J. Hypocretin receptor protein and mRNA expression in the dorsolateral pons of rats. Mol. Brain Res., 2001, 88, 176-182.
52. Hervieu, G.J.; Cluderay, J.E.; Harrison, D.C.; Roberts, J.C.; Leslie, R.A. Gene expression and protein distribution of the orexin-1 receptor in the rat brain and spinal cord. Neuroscience, 2001, 103, 777-797.
53. Lu, X.-Y.; Bagnol, D.; Burke, S.; Akil, H.; Watson, S.J. Differential distribution and regulation of OX1 and OX2 orexin/hypocretin receptor messenger RNA in the brain upon fasting. Hormones Behav., 2000, 37, 335-344.
54. Marcus JN, A.C.; Lee, C.E.; Chemelli, R.M.; Saper, C.B.; Yanagisawa, M.; Elmquist, J.K. Differential expression of orexin receptors 1 and 2 in the rat brain. J. Comp. Neurol., 2001, 435, 6-25.
55. Trivedi, P.; Hong, Y.; Douglas, J.M.; Ploeg, L.H.T.V.d.; Xiao-Ming, G. Distribution of orexin receptor mRNA in the rat brain. FEBS Lett., 1998, 438, 71-75.
56. Rodgers, R.J.; Halford, J.C.G.; Nunes de Souza, R.L.; Canto de Souza, A.L.; Piper, D.C.; Arch, J.R.S.; Upton, N.; Porter, R.A.; Johns, A.; Blundell, J.E. SB-334867, a selective orexin-1 receptor antagonist, enhances behavioural satiety and blocks the hyperphagic effect of orexin-A in rats. Eur. J. Neurosci., 2001, 13, 1444-1452.
57. Rodgers, R.J.; Ishii, Y.; Halford, J.C.G.; Blundell, J.E. Orexins and appetite regulation. Neuropeptides, 2002, 36, 303-325.
58. Haynes, A.C.; Jackson, B.; Chapman, H.; Tadayyon, M.; Johns, A.; Porter, R.A.; Arch, J.R. A selective orexin-1 receptor antagonist reduces food consumption in male and female rats. Regul. Peptides, 2000, 96, 45-51.
59. Ishii, Y.; Blundell, J.E.; Halford, J.C.G.; Upton, N.; Porter, R.; Johns, A.; Rodgers, R.J. Differential effects of the selective orexin-1 receptor antagonist SB-334867 and lithium chloride on the behavioural satiety sequence in rats. Physiol. Behav., 2004, 81, 129-140.
60. Lin, Y.; Matsumura, K.; Tsuchihashi, T.; Abe, I.; Iida, M. Chronic central infusion of orexin-A increases arterial pressure in rats. Brain Res. Bull., 2002, 57, 619-622.
61. Haynes, A.C.; Jackson, B.; Overend, P.; Buckingham, R.E.; Wilson, S.; Tadayyon, M.; Arch, J.R. Effects of single and chronic intracerebroventricular administration of the orexins on feeding in the rat. Peptides, 1999, 20, 1099-1105.
62. Yamanaka, A.; Sakurai, T.; Katsumoto, T.; Masashi, Y.; Goto, K. Chronic intracerebroventricular administration of orexin-A to rats increases food intake in daytime, but has no effect on body weight. Brain Res., 1999, 849, 248-252.
63. Sakurai, T. The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nat. Rev. Neurosci., 2007, 8, 171-181.
64. Funato, H.; Tsai, A.L.; Willie, J.T.; Kisanuki, Y.; Williams, S.C.; Sakurai, T.; Yanagisawa, M. Enhanced orexin receptor-2 signaling prevents diet-induced obesity and improves leptin sensitivity. Cell Metabol., 2009, 9, 64-76.
65. Horvath, T.L. The hardship of obesity: a soft-wired hypothalamus. Nat. Neurosci., 2005, 8, 561-565.
66. Myers, M.G.; Cowley, M.A.; Muenzberg, H. Mechanisms of leptin action and leptin resistance. Annu. Rev. Physiol., 2008, 70, 537-556.
67. Mieda, M.; Williams, S.C.; Richardson, J.A.; Tanaka, K.; Yanagisawa, M. The dorsomedial hypothalamic nucleus as a putative food-entrainable circadian pacemaker. Proc. Natl. Acad. Sci. USA, 2006, 103, 12150-12155.
68. Piper, D.C.; Upton, N.; Smith, M.I.; Hunter, A.J. The novel brain neuropeptide, orexin-A, modulates the sleep-wake cycle of rats. Eur. J. Neurosci., 2000, 12, 726-730.
69. Hagan, J.J.; Leslie, R.A.; Patel, S.; Evans, M.L.; Wattam, T.A.; Holmes, S.; Benham, C.D.; Taylor, S.G.; Routledge, C.; Hemmati, P.; Munton, R.P.; Ashmeade, T.E.; Shah, A.S.; Hatcher, J.P.; Hatcher, P.D.; Jones, D.N.; Smith, M.I.; Piper, D.C.; Hunter, A.J.; Porter, R.A.; Upton, N. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc. Natl. Acad. Sci. USA, 1999, 96, 10911-10916.
70. Smith, M.I.; Piper, D.C.; Duxon, M.S.; Upton, N. Evidence implicating a role for orexin-1 receptor modulation of paradoxical sleep in the rat. Neurosci. Lett., 2003, 341, 256-258.
71. Peyron, C.; Faraco, J.; Rogers, W.; Ripley, B.; Overeem, S.; Charnay, Y.; Nevsimalova, S.; Aldrich, M.; Reynolds, D.; Albin, R.; Li, R.; Hungs, M.; Pedrazzoli, M.; Padigaru, M.; Kucherlapati, M.; Fan, J.; Maki, R.; Lammers, G.J.; Bouras, C.; Kucherlapati, R.; Nishino, S.; Mignot, E. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat. Med., 2000, 6, 991-997.
72. Horvath, T.L., Peyron, C., Diano, S., Ivanov, A., Aston-Jones, G., Kilduff, T.S., van den Pol, A.N. Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system. J. Comp. Neurol., 1999, 415, 145-159.
73. Nakamura, T.; Uramura, K.; Nambu, T.; Yada, T.; Goto, K.; Yanagisawa, M.; Sakurai, T. Orexin-induced hyperlocomotion and stereotypy are mediated by the dopaminergic system. Brain Res., 2000, 873, 181-187.
74. Brown, R.E.; Sergeeva, O.A.; Eriksson, K.S.; Haas, H.L. Convergent excitation of dorsal raphe serotonin neurons by multiple arousal systems (orexin/hypocretin, histamine and noradrenaline). J. Neurosci., 2002, 22, 8850-8859.
75. Liu, R.-J.; van den Pol, A.N.; Aghajanian, G.K. Hypocretins (orexins) regulate serotonin neurons in the dorsal raphe nucleus by excitatory direct and inhibitory indirect actions. J. Neurosci., 2002, 22, 9453-9464.
76. Yamanaka, A.; Tsujino, N.; Funahashi, H.; Honda, K.; Guan, J.-l.; Wang, Q.P.; Tominaga, M.; Goto, K.; Shioda, S.; Sakurai, T. Orexins activate histaminergic neurons via the orexin 2 receptor. Biochem. Biophys. Res. Commun., 2002, 290, 1237-1245.
77. Huang, Z.-L.; Qu, W.-M.; Li, W.-D.; Mochizuki, T.; Eguchi, N.; Watanabe, T.; Urade, Y.; Hayaishi, O. Arousal effect of orexin A depends on activation of the histaminergic system. Proc. Natl. Acad. Sci. USA, 2001, 98, 9965-9970.
78. Bourgin, P.; Huitron-Resendiz, S.; Spier, A.D.; Fabre, V.; Morte, B.; Criado, J.R.; Sutcliffe, J.G.; Henriksen, S.J.; de Lecea, L. Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons. J. Neurosci., 2000, 20, 7760-7765.
79. Takahashi, K.; Koyama, Y.; Kayama, Y.; Yamamoto, M. Effects of orexin on the laterodorsal tegmental neurones. Psychiatry Clin. Neurosci., 2002, 56, 335-336.
80. Xi, M.-C.; Morales, F.R.; Chase, M.H. Effects on sleep and wakefulness of the injection of hypocretin-1 (orexin-A) into the laterodorsal tegmental nucleus of the cat. Brain Res., 2001, 901, 259-264.
81. Takakusaki, K.; Takahashi, K.; Saitoh, K.; Harada, H.; Okumura, T.; Kayama, Y.; Koyama, Y. Orexinergic projections to the cat midbrain mediate alternation of emotional behavioural states from locomotion to cataplexy. J. Physiol., 2005, 568, 1003-1020.
82. Adamantidis, A.R.; Zhang, F.; Aravanis, A.M.; Deisseroth, K.; de Lecea, L. Neural substrates of awakening probed with optogenetic control of hypocretin neurons. Nature, 2007, 450, 420-424.
83. Lee, M.G.; Hassani, O.K.; Jones, B.E. Discharge of identified orexin/hypocretin neurons across the sleep-waking cycle. J. Neurosci., 2005, 25, 6716-6720.
84. Mileykovskiy, B.Y.; Kiyashchenko, L.I.; Siegel, J.M. Behavioral correlates of activity in identified hypocretin/orexin neurons. Neuron, 2005, 46, 787-798.
85. Adamantidis, A.; de Lecea, L. Physiological arousal: a role for hypothalamic systems. Cell. Mol. Life Sci. (CMLS), 2008, 65, 1475-1488.
86. Adamantidis, A.; de Lecea, L. The hypocretins as sensors for metabolism and arousal. J. Physiol., 2009, 587, 33-40.
87. Verret, L.; Goutagny, R.; Fort, P.; Cagnon, L.; Salvert, D.; Léger, L.; Boissard, R.; Salin, P.; Peyron, C.; Luppi, P.H. A role of melanin-concentrating hormone producing neurons in the central regulation of paradoxical sleep. BMC Neurosci., 2003, 4, 19.
88. Bittencourt, J.C.; Presse, F.; Arias, C.; Peto, C.; Vaughan, J.; Nahon, J.L.; Vale, W.; Sawchenko, P.E. The melanin-concentrating hormone system of the rat brain: an immuno- and hybridization histochemical characterization. J. Comp. Neurol., 1992, 218-245.
89. van den Pol, A.N.; Acuna-Goycolea, C.; Clark, K.R.; Ghosh, P.K. Physiological properties of hypothalamic MCH neurons identified with selective expression of reporter gene after recombinant virus infection. Neuron, 2004, 42, 635-652.
90. Li, Y.; van den Pol, A.N. Differential target-dependent actions of coexpressed inhibitory dynorphin and excitatory hypocretin/orexin neuropeptides. J. Neurosci., 2006, 26, 13037-13047.
91. Yamanaka, A.; Beuckmann, C.T.; Willie, J.T.; Hara, J.; Tsujino, N.; Mieda, M.; Tominaga, M.; Yagami, K.; Sugiyama, F.; Goto, K.; Yanagisawa, M.; Sakurai, T. Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron, 2003, 38, 701-713.
92. Balcita-Pedicino, J.J.; Sesack, S.R. Orexin axons in the rat ventral tegmental area synapse infrequently onto dopamine and gamma-aminobutyric acid neurons. J. Comp. Neurol., 2007, 503, 668-684.
93. Boutrel, B.; Kenny, P.J.; Specio, S.E.; Martin-Fardon, R.M.; Markou, A.; Koob, G.F.; de Lecea, L. Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. Proc. Natl. Acad. Sci. USA, 2005, 102, 19168-19173.
94. Narita, M.; Nagumo, Y.; Hashimoto, S.; Narita, M.; Khotib, J.; Miyatake, M.; Sakurai, T.; Yanagisawa, M.; Nakamachi, T.; Shioda, S.; Suzuki, T. Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine. J. Neurosci., 2006, 26, 398-405.
95. Borgland, S.L.; Taha, S.A.; Sarti, F.; Fields, H.L.; Bonci, A. Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron, 2006, 49, 589-601.
96. Georgescu, D.; Zachariou, V.; Barrot, M.; Mieda, M.; Willie, J.T.; Eisch, A.J.; Yanagisawa, M.; Nestler, E.J.; DiLeone, R.J. Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal. J. Neurosci., 2003, 23, 3106-3111.
97. Kuru, M., Ueta, Y., Serino, R., Nakazato, M., Yamamoto, Y., Shibuya, I., Yamashita, H. Centrally administered orexin/hypocretin activates HPA axis in rats. Neuroreport, 2000, 11, 1977-1980.
98. Sakamoto, F.; Yamada, S.; Ueta, Y. Centrally administered orexin-A activates corticotropin-releasing factor-containing neurons in the hypothalamic paraventricular nucleus and central amygdaloid nucleus of rats: possible involvement of central orexins on stress-activated central CRF neurons. Regul. Peptides, 2004, 118, 183-191.
99. Swanson, W. In Handbook of Physiology. Mountcastle, V.; Bloom, F.E.; Geiger, S.R., Eds.; American Physiological Society: Bethesda, 1986, pp. 317-364.
100. Bernardis, L.L.; Awad, A.; Fink, C.; Bellinger, L.L. Metabolic and neuroendocrine indices one month after lateral hypothalamic area lesions. Physiol. Behav., 1992, 52, 133-139.
101. Okada, M. Effect of electrical stimulation of the hypothalamus on cells of the anterior pituitary gland. Osaka Daigaku Igaku Zasshi, 1954, 3, 365-383.
102. Almli, C.R.; Golden, G.T. Infant rats: effects of lateral hypothalamic destruction. Physiol. Behav., 1974, 13, 81-90.
103. Stern, J.E. Electrophysiological and morphological properties of pre-autonomic neurones in the rat hypothalamic paraventricular nucleus. J. Physiol., 2001, 537, 161-177.
104. Samson, W.K.; Taylor, M.M.; Follwell, M.; Ferguson, A.V. Orexin actions in hypothalamic paraventricular nucleus: physiological consequences and cellular correlates. Regul. Peptides, 2002, 104, 97-103.
105. Shirasaka, T.; Nakazato, M.; Matsukura, S.; Takasaki, M.; Kannan, H. Sympathetic and cardiovascular actions of orexins in conscious rats. Am. J. Physiol. Regul. Integr. Comp. Physiol., 1999, 277, R1780-R1785.
106. Hokfelt, T.; Bartfai, T.; Bloom, F. Neuropeptides: opportunities for drug discovery. Lancet Neurol., 2003, 8, 463-472.
107. Mignot, E. Genetic and familial aspects of narcolepsy. Neurology, 1998, 50, S16-S22.
108. Aldrich, M.S. The neurobiology of narcolepsy-cataplexy. Prog. Neurobiol., 1993, 41, 533-541.
109. Nishino, S.; Mignot, E. Pharmacological aspects of human and canine narcolepsy. Prog. Neurobiol., 1997, 52, 27-78.
110. Aldrich, M.S.; Naylor, M.W. Narcolepsy associated with lesions of the diencephalon. Neurology, 1989, 39, 1505-1508.
111. Mitler, M.M.; Boysen, B.G.; Campbell, L.; Dement, W.C. Narcolepsy-cataplexy in a female dog. Exp. Neurol., 1974, 45, 332-340.
112. Foutz AS, M.M.; Cavalli-Sforza, L.L.; Dement, W.C. Genetic factors in canine narcolepsy. Sleep, 1979, 1, 413-421.
113. Lin, L.; Faraco, J.; Li, R.; Kadotani, H.; Rogers, W.; Lin, X.; Qiu, X.; de Jong, P.J.; Nishino, S.; Mignot, E. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell, 1999, 98, 365-376.
114. Mignot, E.; Wang, C.; Rattazzi, C.; Gaiser, C.; Lovett, M.; Guilleminault, C.; Dement, W.C.; Grumet, F.C. Genetic linkage of autosomal recessive canine narcolepsy with a mu immunoglobulin heavy-chain switch-like segment. Proc. Natl. Acad. Sci. USA, 1991, 88, 3475-3478.
115. Guilleminault C.M.E.; Grumet FC. Genetic and familial aspects of narcolepsy. Lancet, 1998, 2, 1376-1379.
116. Willie, J.T.; Chemelli, R.M.; Sinton, C.M.; Tokita, S.; Williams, S.C.; Kisanuki, Y.Y.; Marcus, J.N.; Lee, C.; Elmquist, J.K.; Kohlmeier, K.A.; Leonard, C.S.; Richardson, J.A.; Hammer, R.E.; Yanagisawa, M. Distinct narcolepsy syndromes in orexin receptor-2 and orexin null mice: molecular genetic dissection of non-REM and REM sleep regulatory processes. Neuron, 2003, 38, 715-30.
117. Hara, J.; Beuckmann, C.T.; Nambu, T.; Willie, J.T.; Chemelli, R.M.; Sinton, C.M.; Sugiyama, F.; Yagami, K.; Goto, K.; Yanagisawa, M.; Sakurai, T. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron, 2001, 30, 345-354.
118. Nishino, S.; Ripley, B.; Overeem, S.; Lammers, G.J.; Mignot, E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet, 2000, 355, 39-40.
119. Hartwig, G.; Harsh, J.; Ripley, B.; Nishino, S.; Mignot, E. Low cerebrospinal fluid hypocretin levels found in familial narcolepsy. Sleep Med., 2001, 2, 451-453.
120. Mignot, E.; Lammers, G.J.; Ripley, B.; Okun, M.; Nevsimalova, S.; Overeem, S.; Vankova, J.; Black, J.; Harsh, J.; Bassetti, C.; Schrader, H.; Nishino, S. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch. Neurol., 2002, 59, 1553-1562.
121. Hinze-Selch, D.; Wetter, T.C.; Zhang, Y.; Lu, H.C.; Albert, E.D.; Mullington, J.; Wekerle, H.; Holsboer, F.; Pollmächer, T. In vivo and in vitro immune variables in patients with narcolepsy and HLA-DR2 matched controls. Neurology, 1998, 50, 1149-1152.
122. Scammell, T.E. The neurobiology, diagnosis, and treatment of narcolepsy. Ann. Neurol., 2003, 53, 154-166.
123. Mitler, M.M.; Aldrich, M.S.; Koob, G.F.; Zarcone, V.P. Narcolepsy and its treatment with stimulants. ASDA standards of practice. Sleep, 1994, 17, 352-357.
124. Mieda, M.; Willie, J.T.; Hara, J.; Sinton, C.M.; Sakurai, T.; Yanagisawa, M. Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice. Proc. Natl. Acad. Sci. USA, 2004, 101, 4649-4654.
125. John, J.; Wu, M.F.; Siegel, J.M. Systemic administration of hypocretin-1 reduces cataplexy and normalizes sleep and waking durations in narcoleptic dogs. Sleep Res. Online, 2000, 3, 23-28.
126. Fujiki, N.; Yoshida, Y.; Ripley, B.; Mignot, E.; Nishino, S. Effects of IV and ICV hypocretin-1 (orexin A) in hypocretin receptor-2 gene mutated narcoleptic dogs and IV hypocretin-1 replacement therapy in a hypocretin-ligand-deficient narcoleptic dog. Sleep, 2003, 6, 953-959.
127. Mignot, E.; Nishino, S. Emerging therapies in narcolepsy-cataplexy. Sleep, 2005, 28, 754-763.
128. Hallschmid, M.; Benedict, C.; Born, J.; Fehm, H.L.; Kern, W. Manipulating central nervous mechanisms of food intake and body weight regulation by intranasal administration of neuropeptides in man. Physiol. Behav., 2004, 83, 55-64.
129. Dhuria, S.V.; Hanson, L.R.; Frey, W.H., II. Intranasal drug targeting of hypocretin-1 (orexin-A) to the central nervous system. J. Pharm. Sci., 2008, Epub ahead of print.
130. Yuan, T.-F.; Arias-Carrion, O. Locally induced neural stem cells/pluripotent stem cells for in vivo cell replacement therapy. Int. Arch. Med., 2008, 1, 17.
131. Liu, M.; Thankachan, S.; Kaur, S.; Begum, S.; Blanco-Centurion, C.; Sakurai, T.; Yanagisawa, M.; Neve, R.; Shiromani, P.J. Orexin (hypocretin) gene transfer diminishes narcoleptic sleep behavior in mice. Eur. J. Neurosci., 2008, 28, 1382-1393.
132. Arias-Carrión, O.; Murillo-Rodriguez, E.; Xu, M.; Blanco-Centurion, C.; Drucker-Colín, R.; Shiromani, P.J. Transplantation of hypocretin neurons into the pontine reticular formation: preliminary results. Sleep, 2004, 27, 1465-1470.
133. Arias-Carrión, O.; Drucker-Colín, R.; Murillo- Rodríguez, E. Survival rates through time of hypocretin grafted neurons within their projection site. Neurosci. Lett., 2006, 404, 93-97.
134. Bjorklund, A. Better cells for brain repair. Nature, 1993, 362, 414-415.